Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Ozanimod in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Ozanimod in Alzheimer's disease. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozanimod (ozanimod)

Snippet

Sponsor: ChenXiaoChun | Conditions: Alzheimer Disease | Phase 2 | Status: NOT_YET_RECRUITING